Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
Clin Infect Dis ; 76(11): 2014-2017, 2023 Jun 08.
Artículo en Inglés | MEDLINE | ID: covidwho-2310085

RESUMEN

Using data from 67 Ugandan human immunodeficiency virus (HIV) clinics (July 2019-January 2022), we report a 40% (1005/1662) reduction in the number of people with HIV presenting to care after August 2021 compared to prepandemic levels, with a greater proportion presenting with advanced HIV disease (20% vs 16% in the pre-coronavirus disease 2019 period).


Asunto(s)
COVID-19 , Infecciones por VIH , Humanos , Uganda/epidemiología , Control de Enfermedades Transmisibles , Infecciones por VIH/epidemiología , VIH , Instituciones de Atención Ambulatoria
2.
BMJ Open ; 12(8): e062260, 2022 08 25.
Artículo en Inglés | MEDLINE | ID: covidwho-2020057

RESUMEN

INTRODUCTION: Tuberculosis (TB) is significantly associated with multiple postinfectious, non-communicable diseases after microbiological cure. For example, those with a history of TB disease have a higher risk of developing chronic lung diseases at a younger age. However, the extent and nature of post-TB complications are not well described. Here, we present a protocol for a systematic review and meta-analysis, which aims to synthesise literature on the burden of post-TB lung disease (PTLD) in sub-Saharan Africa, describe phenotypes, long-term outcomes and the health-related quality of life of people with PTLD. METHODS AND ANALYSIS: A systematic search will be conducted using PubMed, EMBASE, Web of Science, African Journals Online and the Cochrane Library of Systematic Reviews. Papers published in English and French languages that report the prevalence, clinical features, quality of life and long-term outcomes of people with PTLD in sub-Saharan Africa will be considered. We will assess and critically appraise the methodological quality of all studies using the modified covidence. Qualitative and quantitative (network and meta-analysis) synthesis will be performed and STATA V.16 will be used to estimate the burden of PTLD. ETHICS AND DISSEMINATION: Ethical approval is not required for this systematic review and meta-analysis. Our results will be published in peer-reviewed journals. PROSPERO REGISTRATION NUMBER: CRD42021274018.


Asunto(s)
Enfermedades Pulmonares , Tuberculosis , África del Sur del Sahara/epidemiología , Humanos , Enfermedades Pulmonares/epidemiología , Enfermedades Pulmonares/etiología , Metaanálisis como Asunto , Calidad de Vida , Revisiones Sistemáticas como Asunto
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA